Lords Mark Unlisted Shares: Price, Financials & IPO Insights
25 August 2025 · Sachin Gadekar
A complete guide on Lords Mark Industries unlisted shares, financial performance, pre-IPO price, and upcoming IPO prospects.
About Lords Mark Industries Limited
Investing in unlisted shares has gained significant popularity as investors look for early opportunities before companies hit the stock market. One such company drawing attention is Lords Mark Industries Limited, a diversified conglomerate making its mark across multiple sectors, including MedTech and renewable energy. In this article, we will explore the Lords Mark unlisted share price, company performance, IPO details, and why investors are closely tracking it.
Founded in 1998, Lords Mark Group started its journey as a paper business and has since grown into a multi-sector conglomerate. Today, the company has a strong presence in:
Renewable energy solutions
In-Vitro Diagnostic (IVD) products
Surgical divisions
MedTech innovations
The company’s strategic focus on healthcare technology and renewable energy is in line with global demand for sustainable and innovative solutions. With this diversification, Lords Mark Industries has positioned itself as a high-growth potential company in the unlisted market.
IPO Details and Pre-IPO Insights
The upcoming Lords Mark Industries IPO listing date is yet to be announced, but investors are actively tracking Lords Mark pre-IPO price today to assess entry points. Pre-IPO shares allow investors to benefit from potential listing gains once the stock goes public.
Lords Mark pre-IPO price: Changing dynamically in unlisted markets
Expected IPO listing: Awaited announcement
Lords Mark pre-IPO date: To be disclosed closer to listing
With the company’s strong performance in healthcare and MedTech, the IPO is expected to generate strong investor interest.
Financial Performance (FY 2023–24)
Lords Mark Industries reported a strong financial turnaround in FY24, reflecting revenue and profit growth.
Key Highlights:
Revenue from operations: ₹555 Crores in FY24 (up from ₹306 Crores in FY23)
Profit Before Tax (PBT): ₹15.6 Crores in FY24 (vs. ₹6.5 Crores in FY23)
Profit After Tax (PAT): ₹11.3 Crores in FY24 (vs. ₹4.6 Crores in FY23)
Operating Expenses: Increased to ₹36.6 Crores in FY24 (up 184%)
Cash Flow:
Operating Activities: -₹21.1 Crores
Investing Activities: -₹17.3 Crores
Financing Activities: +₹47.2 Crores
This growth is driven by rising demand in the MedTech sector and operational expansions.
Financial Data Overview
| Particulars | FY22 | FY23 | FY24 | YOY % FY24 | CAGR % FY24 |
|---|---|---|---|---|---|
| Net Sales | 213.2 | 305.6 | 555.2 | 81.7 | 61.4 |
| Total Income | 214.2 | 306.5 | 556.8 | 81.7 | 61.2 |
| Net Profit | 4.2 | 4.6 | 11.3 | 145.7 | 64 |
| Shareholder Funds | 32.6 | 46.3 | 88.9 | 92 | 65.1 |
| Total Assets | 220.1 | 240.4 | 357.8 | 48.8 | 27.5 |
| EPS | 0.23 | 0.25 | 0.63 | 152 | - |
Lords Mark Industries Annual Report & Fundamentals
The Lords Mark Industries annual report highlights the company’s continued focus on scaling healthcare and renewable energy segments.
Key Fundamentals:
Market Cap: ₹1840.4 Cr.
Debt to Equity Ratio: 0.92
ROE (Return on Equity): 524.53%
Book Value: ₹5.20
Face Value: ₹5.00
P/E Ratio: 0.18
P/B Ratio: 19.62
These fundamentals suggest that while the company is aggressively growing, investors should watch the valuation metrics closely.
Why Investors Are Interested
Strong growth in MedTech and IVD segment – a booming industry.
Revenue and profit growth – significant improvement in FY24.
Upcoming IPO – possible listing gains for early investors.
Diversified business portfolio – across renewable energy, diagnostics, and healthcare.
Active trading in unlisted shares – showing strong demand before IPO.
Risks to Consider
Like any investment, Lords Mark unlisted shares come with risks:
Limited liquidity in unlisted markets.
Lack of publicly available detailed financials.
High valuation multiples.
Dependence on IPO timing and performance.
FAQs
Q1. What is the Lords Mark unlisted share price today?
The Lords Mark unlisted share price varies in the grey market, with its 52-week range between ₹102 and ₹275.
Q2. When is the Lords Mark Industries IPO listing date?
The official IPO listing date is yet to be announced, but investor interest remains strong.
Q3. How can I buy Lords Mark pre-IPO shares?
Investors can buy Lords Mark pre-IPO shares through SEBI-registered platforms like Ultra, which provides access to unlisted shares and other investment opportunities.
Q4. What does the Lords Mark Industries annual report highlight?
The annual report emphasizes strong growth in MedTech, renewable energy, and significant revenue and profit expansion in FY24.
Q5. Is Lords Mark a good investment?
While the company shows promising growth, investors should assess valuation risks and liquidity constraints before investing.
Conclusion
Lords Mark Industries is evolving from a traditional paper business into a futuristic player in healthcare, MedTech, and renewable energy. With a strong financial performance in FY24, increasing demand for its products, and an upcoming IPO, the company has generated significant investor interest in the unlisted shares market.
For investors seeking early exposure, Lords Mark pre-IPO shares provide an opportunity to participate before listing. However, risks around liquidity and valuation must be considered.
At ultra, we provide seamless access to unlisted shares like Lords Mark Industries and other alternative investments to help you diversify and grow your portfolio.